Navigation Links
Self-assembled nano-sized probes allow Penn researchers to see tumors through flesh and skin

Nano-sized particles embedded with bright, light-emitting molecules have enabled researchers to visualize a tumor more than one centimeter below the skin surface using only infrared light. A team of chemists, bioengineers and medical researchers based at the University of Pennsylvania and the University of Minnesota has lodged fluorescent materials called porphyrins within the surface of a polymersome, a cell-like vesicle, to image a tumor within a living rodent. Their findings, which represent a proof of principle for the use of emissive polymersomes to target and visualize tumors, appear in the Feb. 7 online early edition of the Proceedings of the National Academy of Science.

"We have shown that the dispersion of thousands of brightly emissive multi-porphyrin fluorophores within the polymersome membrane can be used to optically image tissue structures deep below the skin ?with the potential to go even deeper," said Michael J. Therien, a professor of chemistry at Penn. "It should also be possible to use an emissive polymersome vesicle to transport therapeutics directly to a tumor, enabling us to actually see if chemotherapy is really going to its intended target."

This work takes advantage of years of effort in the Therien laboratory focused on the design of highly fluorescent compounds. Polymersomes, which were developed by Penn professors Daniel A. Hammer and Dennis Discher in the mid-1990s, function much like the bilayered membranes of living cells. Whereas cell membranes are created from a double layer of fatty phospholipid chains, a polymersome is comprised of two layers of synthetic co-polymers. Like a living cell, the polymersome membrane has a hydrophobic core. The study shows that the fluorophores evenly disperse within this core, giving rise to a nanometer-sized light-emitting structure.

"These polymers are also larger than phospholipids, so that there is enough space for the fluorophores, which are larger than the average molecule that is found inside cell membranes," said Hammer, professor and chair of the Department of Bioengineering at Penn's School of Engineering and Applied Sciences. " Another feature that makes emissive polymersomes so useful is that they self-assemble. Simply mixing together all component parts gives rise to these functional nanometer-sized, cell-like vesicles."

In their study, the researchers demonstrate how they can use these emissive polymersomes to target markers on the surface of a specific type of tumor cells. When exposed to near-infrared light, which can travel through tissue, the fluorophores within the polymersome respond with a bright near-infrared signal that can then be detected.

"The fluorophores function like reflectors stuck in the spokes of a bicycle tire," Therien said. "When this structure absorbs light, it gives rise to an intense, localized fluorescence signal that is uniquely suited for visualizing living biological systems."

According to Therein, there is keen interest in developing new technology that will enable optical imaging of cancer tissue, as such technology will be less costly and more accessible than MRI-based methods and free of the harmful side effects associated with radioactivity. In this imaging system, the flourophores can also be tuned to respond to different wavelengths of near-infrared light. This sets the stage for using emissive polymersomes to target multiple cancer cell-surface markers in the body simultaneously.

Emissive polymersomes perform much like in vivo imaging systems that use semiconductor-based "quantum dots." These quantum dots, however, are hard matter, which could collect within the circulatory system, potentially causing a stroke. According to the Penn researchers, brightly emissive polymersomes define the first nanotech optical imaging platform based on non-aggregating "soft matter" (polymers and porphyrins) and hence have enormous potential in biomedicine.


'"/>

Source:University of Pennsylvania


Related biology news :

1. Self-assembled DNA buckyballs for drug delivery
2. Products containing specific probes for detecting alternative splice forms protected
3. Smart nanoprobes light up disease
4. UC Davis researchers use heated nanoprobes to destroy breast cancer cells in mice
5. York mathematician probes geometric route to combat viruses
6. Researchers find how protein allows insects to detect and respond to pheromones
7. Enzyme allows B cells to resist death, leading to leukemia
8. Tiny scaffolding allows stem cells to become working fat cells
9. Technique may allow cancer patients to freeze eggs, preserving fertility before starting treatment
10. PET/CT can identify new cancer lesions at early stage, allowing for prompt treatment
11. Looks matter to female barn swallows
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/19/2016)... DUBAI , UAE, April 20, 2016 ... can be implemented as a compact web-based "all-in-one" system ... in the biometric fingerprint reader or the door interface ... requirements of modern access control systems. The minimal dimensions ... the ID readers into the building installations offer considerable ...
(Date:4/14/2016)... , April 14, 2016 ... and Malware Detection, today announced the appointment of ... the new role. Goldwerger,s leadership appointment comes ... the heels of the deployment of its platform at ... behavioral biometric technology, which discerns unique cognitive and physiological ...
(Date:3/31/2016)... , March 31, 2016  Genomics firm Nabsys has ... CEO, Barrett Bready , M.D., who returned to ... the original technical leadership team, including Chief Technology Officer, ... Product Development, Steve Nurnberg and Vice President of Software ... the company. Dr. Bready served as CEO ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... ... June 27, 2016 , ... Newly created 4Sight Medical ... to the healthcare market. The company's primary focus is on new product introductions, ... strategies that are necessary to help companies efficiently bring their products to market. ...
(Date:6/24/2016)... , June 24, 2016 Epic ... sensitively detects cancers susceptible to PARP inhibitors by ... tumor cells (CTCs). The new test has already ... therapeutics in multiple cancer types. Over ... DNA damage response pathways, including PARP, ATM, ATR, ...
(Date:6/23/2016)... 2016   Boston Biomedical , an industry ... to target cancer stemness pathways, announced that its ... Drug Designation from the U.S. Food and Drug ... including gastroesophageal junction (GEJ) cancer. Napabucasin is an ... cancer stemness pathways by targeting STAT3, and is ...
(Date:6/23/2016)... Prostate Cancer Foundation (PCF) is pleased to announce 24 new Young ... cancer. Members of the Class of 2016 were selected from a pool of ... More About the Class of 2016 PCF Young Investigators ... ... ...
Breaking Biology Technology: